High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience-Reference-Cited by-同舟云学术

High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience

Published:2020-09-25 Issue:1 Volume:17 Page:123-130
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Yoon Wan‐Soo¹^ORCID,Park Jae‐Sung²,Kim Young‐il³,Chung Dong‐Sup¹,Jeun Sin‐Soo²,Hong Yong‐Kil²,Yang Seung Ho⁴

Affiliation:

1. Department of Neurosurgery Incheon St. Mary's Hospital College of Medicine The Catholic University of Korea Incheon Korea

2. Department of Neurosurgery Seoul St. Mary's Hospital College of Medicine The Catholic University of Korea Seoul Korea

3. Department of Neurosurgery St. Vincent's Hospital College of Medicine The Catholic University of Korea Suwon Korea

4. Department of Neurosurgery St. Vincent's Hospital Cell Death Disease Research Center College of Medicine The Catholic University of Korea Suwon Korea

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13427

Reference30 articles.

1. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

2. Primary malignant lymphomas of the central nervous system

3. Primary central nervous system lymphoma

4. Pharmacokinetic Considerations in the Treatment of CNS Tumours

5. High‐dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma;Hodhoff M;Neurology,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methotrexate-Induced Toxicities in Pediatrics with Malignancy: A Systematic Review and Meta-analysis;INT J MED TOX FORENS;2023

2. Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse;Current Oncology;2022-09-17

3. A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphoma;Journal of Neuro-Oncology;2022-06-22

4. Nanomedicine Applications in Treatment of Primary Central Nervous System Lymphoma: Current State of the Art;Journal of Biomedical Nanotechnology;2021-08-01

5. Methotrexate;Reactions Weekly;2021-02